View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-1186
ICR Reference No:
202203-0920-003
Status:
Historical Active
Previous ICR Reference No:
202004-0920-019
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-22DH
Title:
Information Collection for Tuberculosis Data from Referring Entities to CureTB
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
10/04/2022
Retrieve Notice of Action (NOA)
Date Received in OIRA:
03/17/2022
Terms of Clearance:
In CDC's next revision, extension, or reinstatement request, CDC shall ensure that this collection complies with 5 CFR 1320.8(b)(3) and a submit a copy of all then-effective public guidance issued by CDC on completing this collection (if any) with the package. CDC is also encouraged to consider and report in this next revision, extension, or reinstatement request whether there is a material amount of non-response due to respondent concern about HIPAA or 42 CFR Part 2, and whether steps could be taken to mitigate that non-response.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
02/29/2024
02/29/2024
02/29/2024
Responses
3,914
0
3,764
Time Burden (Hours)
1,103
0
1,081
Cost Burden (Dollars)
31,105
0
30,139
Abstract:
The objective of this information collection is to facilitate CDC coordinating of the continuity of care for individuals affected by TB who enter US jurisdictions from foreign nations who or who leave US jurisdictions bound for foreign nations.
Authorizing Statute(s):
US Code:
42 USC Code of Federal Regulations
Name of Law: Public Health Service Act
US Code:
42 USC Code of Federal Regulations
Name of Law: Part 70 Interstate Quarantine
US Code:
42 USC Code of Federal Regulations
Name of Law: Part 71 Foreign Quarantine
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
84 FR 70555
12/23/2019
30-day Notice:
Federal Register Citation:
Citation Date:
85 FR 36211
06/15/2020
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
7
IC Title
Form No.
Form Name
Coordination with TB Treating Physician/Foreign Health Authority in New Country
n/a
Telephone Script for Clinician/Foreign Health Authority Referral Follow-up
Cure TB Contact Source Investigation (CI/SI) Notification - LHD
n/a
CureTB Contact/Source Investigation (CI/SI) Notification
Cure TB Transnational Notification - Referral from Local Health Departments
n/a
CureTB Transnational Notification
CureTB Partner Feedback (at completion of referred patient's treatment)
n/a
CureTB Partner Feedback
CureTB Partner Feedback (at time of patient referral)
n/a
CureTB Partner Feedback
Individual Followup with Tuberculosis (TB) Patients Referred by ICE
n/a
CureTB Transnational Notificaiton
Individual Followup with Tuberculosis (TB) Patients Referred by LHD
n/a
CureTB Transnational Notification
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
3,914
3,764
0
150
0
0
Annual Time Burden (Hours)
1,103
1,081
0
22
0
0
Annual Cost Burden (Dollars)
31,105
30,139
0
966
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Two short partner feedback surveys (ICs) are being added to assess/improve CDC support and treatment information provided by CDC to public health partners.
Annual Cost to Federal Government:
$234,343
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Renita Macaluso 770 488-6458 arp5@cdc.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
03/17/2022
An official website of the United States government
The .gov means it's official.
The site is secure.
